new version V2017

Brigatinib ALK inhibitors

brigatinib - AP26113      

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

lung cancer (metastatic)

ALTA-1L ongoing brigatinibcrizotinib - NCT02737501